IGM Biosciences shares are trading higher the company priced upsized public offering and concurrent private placement at $8/share.
Portfolio Pulse from Benzinga Newsdesk
IGM Biosciences priced its upsized public offering and concurrent private placement at $8/share, raising $107.3M. The offering includes 3,285,327 shares of voting common stock and 7,312,500 shares of non-voting common stock.
June 22, 2023 | 1:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IGM Biosciences' stock is trading higher after pricing its upsized public offering and concurrent private placement at $8/share, raising $107.3M.
IGM Biosciences' stock is likely to trade higher in the short term due to the successful pricing of its upsized public offering and concurrent private placement. The company raised $107.3M, which could be used for growth and expansion, making it attractive to investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100